Evidence map›Paper›PMID 29336942›Full record

ArticleSexual medicine2018

Malleable Penile Implant Is an Effective Therapeutic Option in Men With Peyronie's Disease and Erectile Dysfunction.

Mohamad Habous, Alaa Tealab, Mohammed Farag, Tarek Soliman, Ben Williamson, Saad Mahmoud, Amin Elserafy, Zenhom Mekawi, Abdallah Remeah, Mohammed Nassar and 6 more

Open access · goldAbstract read
In one paragraph

Article in Sexual medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Editorial Comment: Surgical Management of Peyronie's Disease With Co-Existent Erectile Dysfunction.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 4 countries.

Mohamad HabousElaj Medical Centers, Jeddah, Saudi Arabia. Electronic address: drmhabos@hotmail.com.
Alaa TealabUrology Department, Zagazig University, Zagazig, Egypt.
Mohammed FaragUrology Department, Al-Azhar Faculty of Medicine, Assiut, Egypt.
Tarek SolimanUrology Department, Benha University, Benha, Egypt.
Ben WilliamsonUniversity Hospitals Birmingham, Birmingham, UK.
Saad MahmoudElaj Medical Centers, Jeddah, Saudi Arabia.
Amin ElserafyElaj Medical Centers, Jeddah, Saudi Arabia.
Zenhom MekawiElaj Medical Centers, Jeddah, Saudi Arabia.
Abdallah RemeahElaj Medical Centers, Jeddah, Saudi Arabia.
Mohammed NassarElaj Medical Centers, Jeddah, Saudi Arabia.
Osama LabanUrology Department, King Khaled Hospital, Tabouk, Saudi Arabia.
Osama AbdelwahabUrology Department, Benha University, Benha, Egypt.
Saleh BinsalehDivision of Urology, Department of Surgery, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia.
Simone GionaKing's College Hospital, London, UK.
David RalphSt Peter's Andrology Centre & The Institute of Urology, UCLH, London, UK.
John MulhallSexual and Reproductive Medicine Program, Memorial Sloan Kettering Cancer Center, NY, USA.
Benha University · EGAl-Azhar University · EGKing Khaled Hospital · SAKing's College Hospital · GBMemorial Sloan Kettering Cancer Center · USNIHR Surgical Reconstruction and Microbiology Research Centre · GBSaudi Center for Organ Transplantation · SASt Peter's Hospital · GBZagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe inflatable penile prosthesis (IPP) is typically the preferred implant for Peyronie's disease (PD) and malleable penile prostheses (MPPs) have been discouraged.

aimsTo evaluate the effectiveness and patient satisfaction of the MPP vs IPP in patients with PD.

methodsMen with PD and erectile dysfunction who elected for penile implant surgery constituted the study population. Preoperatively, demographic and comorbidity parameters were recorded. Curvature was measured with a goniometer at maximum rigidity after intracavernosal injection of a vasoactive agent. Postoperatively, overall satisfaction was measured at 3, 6, 12, and 24 months on 5-point Likert scale from 1 (dissatisfied) to 5 (very satisfied).

results166 men with a mean age of 59 ± 10 years were analyzed. The mean preoperative curvature in the entire cohort was 65° (range = 30-130°). 94% of patients with MPP had total resolution of their curvature at the end of the operation, whereas 8 patients (6%) had residual curvature (25-40°). In the IPP group 25 of 30 (83.3%) had a straight penis at the end of surgery, whereas 5 of 30 (16.7%) had residual curvature, with the mean magnitude being 33° in the MPP group and 30° in the IPP group. 86% of all patients had diabetes. There were no differences between the 2 implant groups in age, hemoglobin A

conclusionWe found that the MPP is as effective as the IPP in curvature correction in patients with PD, with similar patient satisfaction for the 2 groups. Habous M, Farag M, Tealab A, et al. Malleable Penile Implant Is an Effective Therapeutic Option in Men With Peyronie's Disease and Erectile Dysfunction. Sex Med 2018;6:24-29.

Indexed as

Erectile DysfunctionInflatable Penile ProsthesisMalleable Penile ProsthesisPenile CurvaturePenile DeformityPeyronie’s Disease

Identifiers

PMID29336942
PMCPMC5815935
OpenAlexW2783573195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.